.
cutting luxuries could give savers extra ?10k in retirement.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
."smoking and drinking � giving these kids a little bit longer to make good decisions in their lives � i'm all for that," bruschi said..
suven life sciences' pashamylaram facility successfully completes usfda inspection
.